Home
Gilead Sciences GILD spent $1.7M on lobbying in Q4 2023 · Trade, Health Issues and 4 more issues
Trade details
- Type
- Lobbying report
- Amount
- $1,680,000
- Quarter
- Q4 2023
- Stock
- Gilead Sciences GILD
- Client
- Gilead Sciences
- Reported
- 24/01/23
Down 29.7% from last quarter
What else happened in Gilead Sciences around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Gilead Sciences's other lobbying reports
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$80K
$80K
Reported 07/20
for Q2
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$80K
$80K
Reported 07/20
for Q2
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$90K
$90K
Reported 07/20
for Q2
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$1.6M
$1.6M
Reported 07/20
for Q2
- Gilead Sciences
LobbyingGilead Sciences
LobbyingGilead Sciences
GILD
$60K
$60K
Reported 07/20
for Q2